Your Health Plan:
Your Health Plan:
Not SelectedUPLIZNA (inebilizumab) is a biologic prescription drug for treatment of Neuromyelitis Optica. UPLIZNA is a cd19-directed cytolytic antibody. It is available in the form of intravenous injection.
See full Prescribing Information for important safety information and clinical studies.
Cash price for 30-day supply is $159900-186900.
Patient Assistance Prorgams and Coupons are found:
No other option is found for UPLIZNA